Charles McCrea Selected Research

Charles McCrea Research Topics

2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2021
2	Clostridium Infections 01/2018 - 10/2016
2	Overactive Urinary Bladder (Overactive Bladder) 06/2017 - 03/2017
1	Disease Progression 01/2021
1	Nausea 01/2021
1	Anemia 01/2021
1	Alopecia (Baldness) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Vomiting 01/2021
1	Body Weight (Weight, Body) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Neoplasms (Cancer) 10/2016

3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2021
2	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2021
2	olaparibIBA 01/2021 - 01/2021
2	Vancomycin FDA LinkGeneric 01/2018 - 10/2016
2	FidaxomicinIBA 01/2018 - 10/2016
2	Muscarinic AntagonistsIBA 06/2017 - 03/2017
2	mirabegronIBA 06/2017 - 03/2017
1	ErbB Receptors (EGF Receptor)IBA 12/2021
1	Hormones (Hormone)IBA 12/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2021
1	PlatinumIBA 01/2021
1	talazoparibIBA 01/2021
1	niraparibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	NivolumabIBA 01/2018
1	Everolimus FDA Link 01/2018
1	Cholinergic Antagonists (Anticholinergics)IBA 06/2017